Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹67.6 Cr -3.2% 45.2% -41.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,185.0 Cr 5.1% 19.9% -16.4% Stock Analytics
KIRI INDUSTRIES ₹2,676.1 Cr 3.6% 17.2% -30.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,509.6 Cr -2.5% 13.9% -31% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,280.3 Cr 0.9% 27.8% 57.5% Stock Analytics
BODAL CHEMICALS ₹856.3 Cr 1.6% 19.1% 0.9% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.2%

45.2%

-41.5%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses